Business

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

Prescription pharmaceutical transdermal fentanyl is a valuable treatment for management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatment for which alternate treatment options are inadequate. Illicit fentanyl and its core precursor chemicals have been designated as weapons of mass destruction to enable the US government to combat the manufacture and distribution by cartels and foreign networks that have flooded the US with illegal f

articleNutriband Inc.December 18, 20256/company/nutriband-inc/news/nutriband-differentiates-prescription-fentanyl-illicit-120000189
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

About this update from Nutriband Inc.

[{"type":"image","alt":"Nutriband Inc.","displaySize":"","headline":null,"caption":"Nutriband Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":82,"url":"https://media.zenfs.com/en/globenewswire.com/e1fe1a06910d514b950ca827bdf3c344"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.H3TZ93yLU_ZLTp_tQ2eWw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e1fe1a06910d514b950ca827bdf3c344","width":300,"height":82}},"lazy":false},{"type":"text","content":"Prescription pharmaceutical transdermal fentanyl is a valuable treatment for management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatment for which alternate treatment options are inadequate.","length":255,"tagName":"p"},{"type":"text","content":"Illicit fentanyl and its core precursor chemicals have been designated as weapons of mass destruction to enable the US government to combat the manufacture and distribution by cartels and foreign networks that have flooded the US with illegal fentanyl.","length":252,"tagName":"p"},{"type":"text","content":"Nutriband is developing Aversa™ Fentanyl, an abuse deterrent fentanyl transdermal system, which combines Nutriband’s proprietary Aversa™ abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch.","length":207,"tagName":"p"},{"type":"text","content":"ORLANDO, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, provides the following response to the Trump Administration’s Executive Order designating illicit fentanyl and its core precursor chemicals as weapons of mass destruction.1","length":355,"tagName":"p"},{"type":"text","content":"“The designation of illicit fentanyl as a weapon of mass destruction reflects the extreme danger posed by illegally manufactured and trafficked fentanyl and fentanyl-laced products. However, this designation must not be conflated with FDA-approved prescription fentanyl therapies, such as transdermal fentanyl patches, which are produced under rigorous regulatory oversight and prescribed to patients suffering from severe chronic pain. These medically necessary products serve a critical role in patient care and access must be maintained while aggressively ...

More updates from Nutriband Inc.

transdermal patchesfentanyl patchfentanyl transdermal systemaccidental exposureNutriband Inc.technologyfentanyl patchespharmaceutical productsweapons of mass destructionChronic pain patients